| Serial Number | 97980518 |
| Word Mark | ULTRAGENYX |
| Filing Date | Wednesday, December 21, 2022 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Tuesday, July 29, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, December 12, 2023 |
| Goods and Services | Education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of rare diseases and disorders; online journals, namely, blogs featuring information on rare diseases and disorders |
| Description of Mark | The mark consists of the word "ultragenyx" in a lower-case stylized font. |
| Goods and Services | Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, inflammatory, autoimmune, musculoskeletal, ophthalmologic, respiratory, osteopathic, oncologic, endocrine, orthopedic, metabolic, lipid-related, genetic, neuromuscular, autosomal, lysosomal storage, enzyme, hematologic and long-chain fatty acid oxidation disorders (LC-FAOD) diseases and disorders; chemical, biological, and biochemical preparations for use in gene delivery technology for medical use, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for use in in vivo therapeutic use in gene therapy |
| Goods and Services | Printed publications, namely, books, brochures, informational pamphlets, informational cards, and advertisements being signs and boards of paper in the field of rare diseases and disorders |
| Pseudo Mark | ULTRA GENE |
| Goods and Services | Financial and insurance consultation services, namely, patient advisory, support and consultancy services regarding patient finances, insurance and access to medical treatment; providing financial and insurance information, namely, providing information and guidance in connection with health insurance benefit plans and other patient financial assistance resources; financial and insurance consultation services, namely, insurance and medical and pharmaceutical access consultation services, namely, assisting patients and their caregivers to identify the scope of coverage offered by patient medical and pharmaceutical insurance and to identify other financial assistance resources for payment of patient treatment; insurance consultation services, namely, assisting patients and their caregivers to obtain authorization and payment for medical and pharmaceutical costs |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Chemical, biological, and biochemical preparations for use in gene delivery technology, namely, nucleic acids, including, coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for use in vitro laboratory use; chemical, biological, and biochemical preparations for use in the manufacture of pharmaceutical preparations |
| Goods and Services | Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, respiratory, and hematologic diseases and disorders; medical consulting services in the field of rare diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of rare diseases and disorders, and collecting data and information on rare diseases and disorders for screening, diagnosis and treatment purposes; medical information services in the nature of providing a database in the field of hypophosphatemia information based on collected patient data and information all for treatment and diagnostic purposes |
| Goods and Services | Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of rare diseases and disorders; medical and scientific research information in the field of rare diseases and disorders; computer services, namely, creating an on-line community for registered users to obtain feedback from their peers, interact with research data, and share data in the field of rare diseases and disorders; pharmaceutical research services, namely, recruitment of rare disease patients for panels such as pharmaceutical research panels; providing medical research and scientific research information in the field of hypophosphatemia |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 18, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | Tuesday, October 31, 2017 |
| First Use In Commerce Date | Tuesday, October 31, 2017 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 18, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, October 31, 2017 |
| First Use In Commerce Date | Tuesday, October 31, 2017 |
| International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
| US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 18, 2023 |
| Primary Code | 016 |
| First Use Anywhere Date | Wednesday, September 30, 2020 |
| First Use In Commerce Date | Wednesday, September 30, 2020 |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 18, 2023 |
| Primary Code | 036 |
| First Use Anywhere Date | Friday, February 24, 2023 |
| First Use In Commerce Date | Friday, February 24, 2023 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 18, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | Friday, January 1, 2021 |
| First Use In Commerce Date | Friday, January 1, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 18, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, September 18, 2021 |
| First Use In Commerce Date | Saturday, September 18, 2021 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 18, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, September 10, 2021 |
| First Use In Commerce Date | Friday, September 10, 2021 |
| Party Name | Ultragenyx Pharmaceutical Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
| Party Name | Ultragenyx Pharmaceutical Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
| Event Date | Event Description |
| Wednesday, January 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 25, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, September 25, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 25, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, November 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 3, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 6, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 22, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 12, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 6, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, August 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 2, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 2, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, August 2, 2024 | SOU EXTENSION 1 FILED |
| Saturday, December 24, 2022 | NEW APPLICATION ENTERED |
| Thursday, September 21, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, December 12, 2023 | PUBLISHED FOR OPPOSITION |
| Friday, August 2, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, August 2, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Friday, August 2, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, August 2, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, January 16, 2025 | SOU EXTENSION 2 FILED |
| Thursday, January 16, 2025 | DIVISIONAL REQUEST RECEIVED |
| Thursday, January 16, 2025 | USE AMENDMENT FILED |
| Thursday, January 16, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, January 16, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 24, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, July 29, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, July 29, 2025 | SOU EXTENSION 2 GRANTED |
| Tuesday, July 29, 2025 | DIVISIONAL PROCESSING COMPLETE |
| Thursday, January 16, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |